Salivary Alpha-Amylase Levels May Correlate With Central Serous Chorioretinopathy Activity

Aliaa H Abdelhakim^{1

2}, Gerardo Ledesma-Gil¹, Lawrence A Yannuzzi¹

Affiliations

¹ Vitreous Retina Macula Consultants of New York, New York.
² Edward S. Harkness Eye Institute, Department of Ophthalmology, Columbia University Medical Center, New York, New York.

Editorial

Aliaa H Abdelhakim et al. Retina. 2021.

. 2021 Oct 1;41(10):2007-2008.

doi: 10.1097/IAE.0000000000003265.

Aliaa H Abdelhakim^{1

2}, Gerardo Ledesma-Gil¹, Lawrence A Yannuzzi¹

¹ Vitreous Retina Macula Consultants of New York, New York.
² Edward S. Harkness Eye Institute, Department of Ophthalmology, Columbia University Medical Center, New York, New York.

No abstract available

Comment on

SALIVARY ALPHA-AMYLASE LEVELS MAY CORRELATE WITH CENTRAL SEROUS CHORIORETINOPATHY ACTIVITY.
Scholz P, Altay L, Sitnilska V, van Dijk EHC, Pereira AM, van Haalen FM, Akhtar I, Boon CJF, Fauser S. Scholz P, et al. Retina. 2021 Dec 1;41(12):2479-2484. doi: 10.1097/IAE.0000000000003266. Retina. 2021. PMID: 34292222

1. Haimovici R, Rumelt S, Melby J. Endocrine abnormalities in patients with central serous chorioretinopathy. Ophthalmology 2003;110:698–703.
1. Bouzas EA, Karadimas P, Pournaras CJ. Central serous chorioretinopathy and glucocorticoids. Surv Ophthalmol 2002;47:431–448.
1. van Dijk EH, Dijkman G, Biermasz NR, et al. Chronic central serous chorioretinopathy as a presenting symptom of Cushing syndrome. Eur J Ophthalmol 2016;26:442.
1. Bouzas EA, Scott MH, Mastorakos G, et al. Central serous chorioretinopathy in endogenous hypercortisolism. Arch Ophthalmol 1993;111:1229–1233.
1. Harada T, Harada K. Six cases of central serous choroidopathy induced by systemic corticosteroid therapy. Doc Ophthalmol 1985;60:37–44.